CAMK2G and chronic myelogenous leukemia, BCR-ABL1 positive: Cell culture and animal models of acute myeloid leukemia (AML), chronic myeloid leukemia (CML), Burkitt’s lymphoma, and ALL exhibit increased expression and activation of CaMKII [21,24,27–29].